Robert Fishman - Sep 1, 2022 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role: Chief Medical Officer
Signature: /s/ August J. Moretti, Attorney-in-Fact for Robert Fishman
Stock symbol: FDMT
Transactions as of: Sep 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/6/2022, 08:42 PM
Previous filing: Feb 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FDMT	Stock Option (Right to Buy)	Award	$0	+60K		$0.00	60K	Sep 1, 2022	Common Stock	60K	$8.04	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Content

The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of September 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.